Base de dados : MEDLINE
Pesquisa : N02.421.726.758 [Categoria DeCS]
Referências encontradas : 16379 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 1638 ir para página                         

  1 / 16379 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29203750
[Au] Autor:Pashkov VM; Batyhina OM; Trotska MV
[Ad] Endereço:Poltava Law Institute Of Yaroslav The Wise National Law University, Poltava, Ukraine.
[Ti] Título:Concept of waste and its impact on human health.
[So] Source:Wiad Lek;70(5):964-969, 2017.
[Is] ISSN:0043-5147
[Cp] País de publicação:Poland
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Impact of the environment on human health is increasingly being paid attention both at the international level and at the level of individual countries. Among the factors that anyhow can affect it negatively, various objects are distinguished and waste is not of the last consequence. It has different nature of origin, ways of further utilization and a degree of impact on human health and the environment. Its generation, utilization and neutralization are determined by the relevant processes; their research allows continuous improvement and reduction of their negative impact on human health and the environment. THE AIM: To analyze provisions of the international legislation concerning the concept of waste and its classification, as well as its potential impacts on human health and the environment. MATERIALS AND METHODS: The study analyzes and uses international legal documents, data of international organizations and scientists' deductions. Furthermore, the study integrates information from scientific journals with scientific methods from the medical and legal point of view. Within the framework of the system approach, as well as analysis and synthesis, the concept of waste, its classification and impact on human health and the environment have been researched. RESULTS: In consequence of the conducted study, it has been found that at the European level, considerable attention is paid to waste in the context of its possible negative impact on human health and the environment. Solution of this problem is carried out with the integrated approach, which is expressed both in enacting statutory acts and amending existing ones, as well as elucidating various aspects at the scientific, methodological, statistical and other levels. CONCLUSIONS: Waste in itself has different nature of origin, negative impact, ways of its further utilization. Some kinds of it can be used further in order to achieve other goals and needs that are not related to their generation, others can no longer be used for human benefits taking into account existing achievements.
[Mh] Termos MeSH primário: Exposição Ambiental
Saúde Ambiental
Poluição Ambiental
Nível de Saúde
Saúde Pública
[Mh] Termos MeSH secundário: Ecologia
Seres Humanos
Prevenção Primária
Fatores de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180308
[Lr] Data última revisão:
180308
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171206
[St] Status:MEDLINE


  2 / 16379 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28749331
[Au] Autor:Heil J; Ter Waarbeek HLG; Hoebe CJPA; Jacobs PHA; van Dam DW; Trienekens TAM; Cals JWL; van Loo IHM; Dukers-Muijrers NHTM
[Ad] Endereço:Department of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service, Geleen, the Netherlands.
[Ti] Título:Pertussis surveillance and control: exploring variations and delays in testing, laboratory diagnostics and public health service notifications, the Netherlands, 2010 to 2013.
[So] Source:Euro Surveill;22(28), 2017 Jul 13.
[Is] ISSN:1560-7917
[Cp] País de publicação:Sweden
[La] Idioma:eng
[Ab] Resumo:Pertussis is most severe among unvaccinated infants (< 1 year of age), and still leads to several reported deaths in the Netherlands every year. In order to avoid pertussis-related infant morbidity and mortality, pertussis surveillance data are used to guide pertussis control measures. However, more insight into the accuracy of pertussis surveillance and control, and into the range of healthcare and public health-related factors that impede this are needed. We analysed a unique combination of data sources from one Dutch region of 1.1 million residents, including data from laboratory databases and local public health notifications between 2010 and 2013. This large study (n = 12,090 pertussis tests) reveals possible misdiagnoses, substantial under-notification (18%, 412/2,301 laboratory positive episodes) and a delay between patient symptoms and notification to the local public health services (median 34 days, interquartile range (IQR): 27-54). It is likely that the misdiagnoses, under-notification and overall delay in surveillance data are not unique to this area of the Netherlands, and are generalisable to other countries in Europe. In addition to preventive measures such as maternal immunisation, based on current findings, we further recommend greater adherence to testing guidelines, standardisation of test interpretation guidelines, use of automatic notification systems and earlier preventive measures.
[Mh] Termos MeSH primário: Bordetella pertussis/isolamento & purificação
Técnicas de Laboratório Clínico/métodos
Notificação de Doenças/métodos
Notificação Compulsória
Prevenção Primária/métodos
Coqueluche/diagnóstico
[Mh] Termos MeSH secundário: Técnicas de Laboratório Clínico/normas
Notificação de Doenças/normas
Feminino
Seres Humanos
Imunização
Incidência
Lactente
Masculino
Países Baixos/epidemiologia
Vigilância da População
Garantia da Qualidade dos Cuidados de Saúde
Vigilância de Evento Sentinela
Inquéritos e Questionários
Estados Unidos
United States Public Health Service
Coqueluche/epidemiologia
Coqueluche/prevenção & controle
Coqueluche/transmissão
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180306
[Lr] Data última revisão:
180306
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170728
[St] Status:MEDLINE


  3 / 16379 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29406627
[Au] Autor:Geckle J
[Ti] Título:Use of Multimedia or Mobile Devices By Adolescents for Health Promotion and Disease Prevention: A Literature Review.
[So] Source:Pediatr Nurs;42(4):163-7, 2016 Jul-Aug.
[Is] ISSN:0097-9805
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The purpose of this literature review is to summarize studies of the use of multimedia technology by adolescents to engage in their healthcare promotion and disease prevention. A systematic literature review of relevant peer-reviewed research published between 2009 and 2014 was performed. The 16 articles reviewed were a combination of quantitative and mixed-method methodology based on the efficacy of multimedia, mobile technology, Short Messaging Services (SMS) texting, and social networking (e.g., Facebook®), to engage adolescents ages 10 to 20 years in health promotion and disease prevention. Although adolescents have high attrition rates in the studies, they demonstrated advantages in using SMS texting features and social networking, especially the chat function, in relation to health promotion and disease prevention. Some small gains were noticed in health promotion and disease prevention in the majority of the studies, though some were not significant due to attrition. Additional research, especially nursing research, is necessary. Mobile and multimedia technology allows for a promising correlation between adolescents and increased healthcare knowledge, health promotion, and disease prevention.
[Mh] Termos MeSH primário: Promoção da Saúde/métodos
Promoção da Saúde/estatística & dados numéricos
Armazenamento e Recuperação da Informação/métodos
Multimídia/utilização
Recursos Humanos de Enfermagem/educação
Prevenção Primária/métodos
Mensagem de Texto/utilização
[Mh] Termos MeSH secundário: Adolescente
Educação Continuada em Enfermagem/métodos
Feminino
Seres Humanos
Masculino
Multimídia/estatística & dados numéricos
Mensagem de Texto/estatística & dados numéricos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180305
[Lr] Data última revisão:
180305
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:180207
[St] Status:MEDLINE


  4 / 16379 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29406659
[Au] Autor:Rollins JA
[Ti] Título:Sharing a Room: Updated Recommendations for a Safe Infant Sleeping Environment.
[So] Source:Pediatr Nurs;43(1):7, 14, 2017 Jan-Feb.
[Is] ISSN:0097-9805
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Leitos
Promoção da Saúde
Gestão da Segurança/métodos
Sono
Morte Súbita do Lactente/prevenção & controle
[Mh] Termos MeSH secundário: Aleitamento Materno
Meio Ambiente
Seres Humanos
Lactente
Recém-Nascido
Prevenção Primária
Fatores de Risco
Sociedades Médicas
Estados Unidos
[Pt] Tipo de publicação:EDITORIAL
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180301
[Lr] Data última revisão:
180301
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:180207
[St] Status:MEDLINE


  5 / 16379 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29240656
[Au] Autor:Rondinelli J; Zuniga S; Kipnis P; Kawar LN; Liu V; Escobar GJ
[Ad] Endereço:June Rondinelli, PhD, RN, CNS, is Nurse Scientist and Interim Director, Regional Nursing Research Program, Kaiser Permanente, Southern California, Pasadena. Stephen Zuniga, PhD, is Biostatistician II, Clinical Intelligence and Decision Support, Kaiser Foundation Hospitals, Pasadena, California. Patricia Kipnis, PhD, is Principal Statistician/Associate Director, Decision Support, Kaiser Foundation Hospitals, Oakland, California. Lina Najib Kawar, PhD, RN, CNS, is Nurse Scientist, Regional Nursing Research Program, Kaiser Permanente, Southern California, Pasadena. Vincent Liu, MD, MS, is Research Scientist, Division of Research, Kaiser Permanente, Oakland, California. Gabriel J. Escobar, MD, is Research Scientist III, Regional Director for Hospital Operations Research, Division of Research, Kaiser Permanente, Oakland, California.
[Ti] Título:Hospital-Acquired Pressure Injury: Risk-Adjusted Comparisons in an Integrated Healthcare Delivery System.
[So] Source:Nurs Res;67(1):16-25, 2018 Jan/Feb.
[Is] ISSN:1538-9847
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Although healthcare organizations have decreased hospital-acquired pressure injury (HAPI) rates, HAPIs are not eliminated, driving further examination in both nursing and health services research. OBJECTIVE: The objective was to describe HAPI incidence, risk factors, and risk-adjusted hospital variation within a California integrated healthcare system. METHODS: Inpatient episodes were included in this retrospective cohort if patients were hospitalized between January 1, 2013, and June 30, 2015. The primary outcome was development of a HAPI over time. Predictors included cited HAPI risk factors in addition to incorporation of a longitudinal comorbidity burden (Comorbidity Point Score, Version 2 [COPS2]), a severity-of-illness score (Laboratory-Based Acute Physiology Score, Version 2 [LAPS2]), and the Braden Scale for Predicting Pressure Ulcer Risk. RESULTS: Analyses included HAPI inpatient episodes (n = 1661) and non-HAPI episodes (n = 726,605). HAPI incidence was 0.57 per 1,000 patient days (95% CI [0.019, 3.805]) and 0.2% of episodes. A multivariate Cox proportional hazards model showed significant (p < .001) hazard ratios (HRs) for the change from the 25th to the 75th percentile for age (HR = 1.36, 95% CI [1.25, 1.45]), higher COPS2 scores (HR = 1.10, 95% CI [1.04, 1.16]), and higher LAPS2 scores (HR = 1.38, 95% CI [1.28, 1.50]). Female gender, an emergency room admission for a medical reason, and higher Braden scores showed significant protective HRs (HR < 1.00, p < .001). After risk adjustment, significant variation remained among the 35 hospitals. DISCUSSION: Results prompt the consideration of age, severity of illness (LAPS2), comorbidity indexes (COPS2), and the Braden score as important predictors for HAPI risk. HAPI rates may be low; however, because of significant individual site variation, HAPIs remain an area to explore through both research and quality improvement initiatives.
[Mh] Termos MeSH primário: Lesão por Pressão/epidemiologia
Lesão por Pressão/prevenção & controle
Prevenção Primária/métodos
Índice de Gravidade de Doença
Higiene da Pele/métodos
[Mh] Termos MeSH secundário: Adulto
Idoso
Estudos de Coortes
Feminino
Seres Humanos
Pacientes Internados/estatística & dados numéricos
Masculino
Meia-Idade
Modelos de Riscos Proporcionais
Melhoria de Qualidade
Estudos Retrospectivos
Medição de Risco/estatística & dados numéricos
Fatores de Risco
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1712
[Cu] Atualização por classe:180302
[Lr] Data última revisão:
180302
[Sb] Subgrupo de revista:AIM; IM; N
[Da] Data de entrada para processamento:171215
[St] Status:MEDLINE
[do] DOI:10.1097/NNR.0000000000000258


  6 / 16379 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29338456
[Au] Autor:Cicero AFG; Colletti A
[Ad] Endereço:a Medical and Surgical Sciences Department , University of Bologna , Bologna , Italy.
[Ti] Título:An update on the safety of nutraceuticals and effects on lipid parameters.
[So] Source:Expert Opin Drug Saf;17(3):303-313, 2018 Mar.
[Is] ISSN:1744-764X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Cardiovascular diseases (CVDs) are the leading cause of mortality and disability in developed countries, whereas a large portion of patients in primary prevention have uncontrolled level of CVD risk factors. Dietary supplementation with bioactive natural compounds with demonstrated lipid-lowering effects is currently supported by the international guidelines for CVD prevention and some international expert panels. Areas covered: This review provides insights on issues concerning the tolerability and safety of the most commonly used nutraceuticals with demonstrated lipid-lowering effect in humans. They will be then divided into three main categories according to their mechanism of action (cholesterol synthesis inhibitors, intestinal cholesterol absorption inhibitors, and LDL-C excretion stimulants) and their pharmacological profile will be discussed. Expert opinion: A growing body of preclinical, epidemiological and clinical evidence has defined the tolerability and safety profile of the most commonly used lipid-lowering nutraceuticals. In the most part of cases, the side effects are mild and reversible. However, detailed knowledge of specific health risks and pharmacological interactions for each individual compound is needed for the management of frail patients, such as children, elderly, patients with liver or renal failure, and patients consuming numerous drugs.
[Mh] Termos MeSH primário: Doenças Cardiovasculares/prevenção & controle
Suplementos Nutricionais
Lipídeos/sangue
[Mh] Termos MeSH secundário: Idoso
Doenças Cardiovasculares/etiologia
Criança
Colesterol/metabolismo
LDL-Colesterol/metabolismo
Suplementos Nutricionais/efeitos adversos
Seres Humanos
Guias de Prática Clínica como Assunto
Prevenção Primária/métodos
Fatores de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Cholesterol, LDL); 0 (Lipids); 97C5T2UQ7J (Cholesterol)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180215
[Lr] Data última revisão:
180215
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180118
[St] Status:MEDLINE
[do] DOI:10.1080/14740338.2018.1429404


  7 / 16379 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29253402
[Au] Autor:Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
[Ad] Endereço:Cancer Council NSW, Cancer Research Division, Sydney, NSW, Australia.
[Ti] Título:Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
[So] Source:Lancet Public Health;2(2):e96-e107, 2017 Feb.
[Is] ISSN:2468-2667
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Australia's National Cervical Screening Program currently recommends cytological screening every 2 years for women aged 18-69 years. Human papillomavirus (HPV) vaccination was implemented in 2007 with high population coverage, and falls in high-grade lesions in young women have been reported extensively. This decline prompted a major review of the National Cervical Screening Program and new clinical management guidelines, for which we undertook this analysis. METHODS: We did effectiveness modelling and an economic assessment of potential new screening strategies, using a model of HPV transmission, vaccination, natural history, and cervical screening. First, we evaluated 132 screening strategies, including those based on cytology and primary HPV testing. Second, after a recommendation was made to adopt primary HPV screening with partial genotyping and direct referral to colposcopy of women positive for HPV16/18, we evaluated the final effect of HPV screening after incorporating new clinical guidelines for women positive for HPV. Both evaluations considered both unvaccinated and vaccinated cohorts. FINDINGS: Strategies entailing HPV testing every 5 years and either partial genotyping for HPV16/18 or cytological co-testing were the most effective. One of the most effective and cost-effective strategies comprised primary HPV screening with referral of women positive for oncogenic HPV16/18 direct to colposcopy, with reflex cytological triage for women with other oncogenic types and direct referral for those in this group with high-grade cytological findings. After incorporating detailed clinical guidelines recommendations, this strategy is predicted to reduce cervical cancer incidence and mortality by 31% and 36%, respectively, in unvaccinated cohorts, and by 24% and 29%, respectively, in cohorts offered vaccination. Furthermore, this strategy is predicted to reduce costs by up to 19% for unvaccinated cohorts and 26% for cohorts offered vaccination, compared with the current programme. INTERPRETATION: Primary HPV screening every 5 years with partial genotyping is predicted to be substantially more effective and potentially cost-saving compared with the current cytology-based screening programme undertaken every 2 years. These findings underpin the decision to transition to primary HPV screening with partial genotyping in the Australian National Cervical Screening Program, which will occur in May, 2017. FUNDING: Department of Health, Australia.
[Mh] Termos MeSH primário: Detecção Precoce de Câncer/economia
Detecção Precoce de Câncer/métodos
Infecções por Papillomavirus/diagnóstico
Vacinas contra Papillomavirus/administração & dosagem
Neoplasias do Colo do Útero/diagnóstico
[Mh] Termos MeSH secundário: Adolescente
Adulto
Idoso
Austrália
Biologia Celular/economia
Análise Custo-Benefício
Testes Diagnósticos de Rotina/economia
Feminino
Seres Humanos
Meia-Idade
Infecções por Papillomavirus/prevenção & controle
Prevenção Primária/economia
Avaliação de Programas e Projetos de Saúde
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Papillomavirus Vaccines)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180214
[Lr] Data última revisão:
180214
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171219
[St] Status:MEDLINE


  8 / 16379 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Registro de Ensaios Clínicos
Texto completo
[PMID]:29212812
[Au] Autor:Dewland TA; Soliman EZ; Yamal JM; Davis BR; Alonso A; Albert CM; Simpson LM; Haywood LJ; Marcus GM
[Ad] Endereço:From the Knight Cardiovascular Institute, Oregon Health & Science University, Portland (T.A.D.); Cardiology Section, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, NC (E.Z.S.); University of Texas School of Public Health, Houston (J.-M.Y., B.R.D., L.M.S.); Depart
[Ti] Título:Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
[So] Source:Circ Arrhythm Electrophysiol;10(12), 2017 Dec.
[Is] ISSN:1941-3084
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Although atrial fibrillation (AF) guidelines indicate that pharmacological blockade of the renin-angiotensin system may be considered for primary AF prevention in hypertensive patients, previous studies have yielded conflicting results. We sought to determine whether randomization to lisinopril reduces incident AF or atrial flutter (AFL) compared with chlorthalidone in a large clinical trial cohort with extended post-trial surveillance. METHODS AND RESULTS: We performed a secondary analysis of the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial), a randomized, double-blind, active-controlled clinical trial that enrolled hypertensive individuals ≥55 years of age with at least one other cardiovascular risk factor. Participants were randomly assigned to receive amlodipine, lisinopril, or chlorthalidone. Individuals with elevated fasting low-density lipoprotein cholesterol levels were also randomized to pravastatin versus usual care. The primary outcome was the development of either AF or AFL as diagnosed by serial study ECGs or by Medicare claims data. Among 14 837 participants without prevalent AF or AFL, 2514 developed AF/AFL during a mean 7.5±3.2 years of follow-up. Compared with chlorthalidone, randomization to either lisinopril (hazard ratio, 1.04; 95% confidence interval, 0.94-1.15; =0.46) or amlodipine (hazard ratio, 0.93; 95% confidence interval, 0.84-1.03; =0.16) was not associated with a significant reduction in incident AF/AFL. CONCLUSIONS: Compared with chlorthalidone, treatment with lisinopril is not associated with a meaningful reduction in incident AF or AFL among older adults with a history of hypertension. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000542.
[Mh] Termos MeSH primário: Anlodipino/uso terapêutico
Anti-Hipertensivos/uso terapêutico
Fibrilação Atrial/prevenção & controle
Flutter Atrial/prevenção & controle
Clortalidona/uso terapêutico
Hipertensão/tratamento farmacológico
Lisinopril/uso terapêutico
Infarto do Miocárdio/prevenção & controle
Prevenção Primária/métodos
[Mh] Termos MeSH secundário: Anlodipino/efeitos adversos
Anti-Hipertensivos/efeitos adversos
Fibrilação Atrial/diagnóstico
Fibrilação Atrial/epidemiologia
Fibrilação Atrial/fisiopatologia
Flutter Atrial/diagnóstico
Flutter Atrial/epidemiologia
Flutter Atrial/fisiopatologia
Clortalidona/efeitos adversos
Método Duplo-Cego
Feminino
Seres Humanos
Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico
Hipertensão/diagnóstico
Hipertensão/epidemiologia
Hipertensão/fisiopatologia
Incidência
Lisinopril/efeitos adversos
Masculino
Meia-Idade
Infarto do Miocárdio/diagnóstico
Infarto do Miocárdio/epidemiologia
Infarto do Miocárdio/fisiopatologia
Fatores de Risco
Fatores de Tempo
Resultado do Tratamento
Estados Unidos/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL
[Nm] Nome de substância:
0 (Antihypertensive Agents); 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors); 1J444QC288 (Amlodipine); E7199S1YWR (Lisinopril); Q0MQD1073Q (Chlorthalidone)
[Em] Mês de entrada:1712
[Cu] Atualização por classe:180207
[Lr] Data última revisão:
180207
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171208
[Cl] Clinical Trial:ClinicalTrial
[St] Status:MEDLINE


  9 / 16379 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28745556
[Au] Autor:Berntsen S; Karlsen APH; Pedersen ML; Mulvad G
[Ad] Endereço:a Queen Ingrid Health Care Center , Nuuk , Greenland.
[Ti] Título:Gonorrhoea in Greenland, incidence and previous preventive measures: a review to improve future strategies.
[So] Source:Int J Circumpolar Health;76(1):1350092, 2017.
[Is] ISSN:2242-3982
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Gonorrhoea continues to be a significant health challenge in Greenland. The aim of this study was to describe the development of gonorrhoea in Greenland through time including incidence rates and previous measures taken to address the challenge. A systematic literature search in PubMed, Embase and The Cochrane Library was conducted. Furthermore, local archives were searched in the Health Clinic in Nuuk for relevant literature. From the 1940s the incidence of gonorrhoea increased steadily with a steep incline around 1970, possibly as a consequence of changes in living conditions and urbanisation. Significant declines in the incidence were seen the late 1970s and again in the late 1980s, most likely in the wake of an outbreak of ulcus molle/chancroid in the 1970s and as a result of focused education in venereology for Greenlandic nurses in the late 1980s combined with the stop-AIDS campaign. Since the early 1990s the incidence of gonorrhoea in Greenland has not risen to previously high levels. However, the incidence remains high and with a gradually increasing trend. Prevention intervention strategies such as peer-to-peer sexual education, storytelling and involvement of parent/guardian in sexual education of the youth could be appropriate approaches to improve sexual health in Greenland.
[Mh] Termos MeSH primário: Serviços de Saúde Comunitária/organização & administração
Gonorreia/epidemiologia
Gonorreia/prevenção & controle
Prevenção Primária/organização & administração
Comportamento Sexual/estatística & dados numéricos
[Mh] Termos MeSH secundário: Busca de Comunicante
Feminino
Gonorreia/diagnóstico
Groenlândia
Seres Humanos
Masculino
Neisseria gonorrhoeae/isolamento & purificação
Prevalência
Estudos Retrospectivos
Fatores de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1711
[Cu] Atualização por classe:180202
[Lr] Data última revisão:
180202
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170727
[St] Status:MEDLINE
[do] DOI:10.1080/22423982.2017.1350092


  10 / 16379 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28466467
[Au] Autor:Kramer K; Verweij MF; Zaaijer HL
[Ad] Endereço:Department of Blood-borne Infections (BOI), Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
[Ti] Título:Are there ethical differences between stopping and not starting blood safety measures?
[So] Source:Vox Sang;112(5):417-424, 2017 Jul.
[Is] ISSN:1423-0410
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND AND OBJECTIVES: Concern with the costs of blood safety is growing, which raises the question whether safety measures that reduce risk only marginally should be discontinued. Withdrawing such safety measures would allow reallocating resources to more efficient health care interventions, but it might raise moral objections. MATERIALS AND METHODS: This study evaluates two ethical arguments why discontinuing blood safety measures would be more objectionable than not implementing them. The first argument is that whereas withdrawing protective measures causes harm to patients, not starting protective measures 'merely' omits to prevent harm. The second argument is that patients who benefit from protective measures are historically entitled to the continuation of those protective measures. RESULTS: Both arguments are unconvincing. There is only a weak causal connection between removing blood safety measures and harms that transfusion recipients suffer. Moreover, patients are not entitled to the continuation of protective measures that prove very inefficient, unless applying these protective measures rectifies past injustice towards them. CONCLUSION: Unless stronger ethical objections can be found, blood system operators and regulators should be more willing to withdraw inefficient safety measures.
[Mh] Termos MeSH primário: Segurança do Sangue/ética
[Mh] Termos MeSH secundário: Segurança do Sangue/economia
Segurança do Sangue/métodos
Transfusão de Sangue/economia
Transfusão de Sangue/ética
Seres Humanos
Prevenção Primária
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180201
[Lr] Data última revisão:
180201
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170504
[St] Status:MEDLINE
[do] DOI:10.1111/vox.12525



página 1 de 1638 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde